Key Takeaways
- Record quarterly net revenue of $206.7M marked an 11% year-over-year increase, surpassing the $201.35M consensus forecast
- Company posted adjusted earnings of $0.02 per share, defying analyst projections of a -$0.14 loss
- The cannabis division expanded 19% to reach $64.8M, fueled by a remarkable 73% international cannabis revenue increase
- Adjusted EBITDA climbed 19% to reach $10.7M; management maintains fiscal 2026 outlook of $62M–$72M
- Company finalized BrewDog acquisition for approximately £40M and unveiled Carlsberg collaboration launching in 2027
Tilray Brands delivered a standout performance in its third quarter of fiscal 2026, achieving record-breaking net revenue of $206.7 million. This represents an impressive 11% increase compared to the $185.8 million generated during the equivalent period last year, exceeding analyst projections.
The most significant story was the earnings shock. Wall Street had anticipated a per-share loss of 14 cents. Instead, Tilray delivered an adjusted profit of $0.02 per share. Such dramatic beats typically trigger strong market reactions, and TLRY responded with an 8.01% surge.
The company reported a net loss of $25.2 million for the period, which may appear concerning at first glance, but represents a dramatic turnaround from the staggering $793.5 million loss recorded in the comparable quarter of the previous year.
Gross profit reached $55.0 million, representing a 6% year-over-year gain, while the consolidated gross margin stood at 27%.
The cannabis segment delivered particularly impressive results. Overall cannabis revenue expanded 19% to $64.8 million. International cannabis net revenue skyrocketed 73%, while cannabis flower sales volume doubled compared to the prior year.
Canadian adult-use and medical cannabis net revenue increased 8%, solidifying Tilray’s position as Canada’s top cannabis revenue generator.
The distribution business also performed exceptionally well. It achieved a quarterly record of $83.0 million in net revenue, with distribution gross profit climbing to $10.0 million and margins expanding to 12%.
Tilray successfully concluded its Project 420 synergy initiative during the quarter. This program generated roughly $33 million in annualized cost reductions.
Strategic Acquisitions and International Expansion
Following the close of the quarter, Tilray finalized its purchase of BrewDog, the prominent UK craft brewery, for roughly £40 million in cash. Chief Executive Irwin Simon indicated the acquisition enables the company to construct a “scaled global beverage platform.”
Additionally, Tilray unveiled a strategic alliance with Carlsberg, scheduled to commence in 2027. According to company statements, this collaboration extends its footprint throughout Europe, the Middle East, Australia, Asia-Pacific regions, and the United States.
Adjusted EBITDA for the third quarter totaled $10.7 million, marking a 19% improvement from the $9.0 million achieved in the year-ago period.
Financial Outlook Maintained
Executive leadership reaffirmed its fiscal 2026 adjusted EBITDA projection of $62 million to $72 million. This target range indicates anticipated growth of 13% to 31% versus fiscal year 2025 results.
Analyst sentiment on TLRY currently reflects a Hold consensus, derived from one Buy recommendation and five Hold ratings issued within the last three months. The mean price target stands at $8.97, suggesting potential upside of approximately 38.64% from current trading levels.
Notwithstanding the strong Q3 performance, TLRY shares remain down 28.35% year-to-date and have declined 0.68% over the trailing twelve-month period.
The post Tilray Brands (TLRY) Stock Surges 8% Following Stellar Q3 Earnings Report appeared first on Blockonomi.

1 hour ago
10
Revenue: $206.73M Vs. $203M est.
International cannabis surged 73% YoY, while distribution reached a record $83M, offsetting beverage weakness. 







English (US) ·